Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma
Status:
Completed
Trial end date:
2019-07-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to clarify the impact of rituximab on clinical outcomes in
patients with primary breast diffuse large B-cell lymphoma and also to investigate the role
of prophylactic intrathecal chemotherapy using methotrexate for reducing central nervous
system (CNS) recurrence.
Phase:
Phase 2
Details
Lead Sponsor:
Chonbuk National University Hospital
Collaborators:
Consortium for Improving Survival of Lymphoma Consortium for Improving Survival on Lymphoma